GRIA1 and Alzheimer disease: Indeed, in 3xTg-AD mice at 3 m.o.a., we found up-regulation of GluA3 and GluA4 expression while GluA1 and GluA2 remained stable (Figure 1C), thereby suggesting a functional switch toward different heterotetrameric AMPAR configurations.